Harbor Asset Planning’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$62.9K Hold
441
– – 0.05% 198
2026
Q2
$69.1K Hold
441
– – 0.05% 187
2026
Q1
$67.4K Hold
441
– – 0.06% 177
2025
Q4
$60.8K Hold
441
– – 0.05% 178
2025
Q3
$56.6K Hold
441
– – 0.05% 177
2025
Q2
$53.4K Buy
+441
New +$49.7K 0.05% 175

Other funds holding NVS

Harbor Asset Planning's NVS Position: Q3 2026 in Review

Harbor Asset Planning held its Novartis (NVS) position steady in Q3 2026 at 441 shares worth $62.9K. The position accounts for 0.05% of the portfolio, ranked #198.

Harbor Asset Planning first reported a position in NVS in Q2 2025 and has held it in 6 quarters since. The position peaked at $69.1K in Q2 2026. 1,256 funds tracked by Wall St. Rank hold NVS as of Q3 2026.

  • Harbor Asset Planning held 441 shares of Novartis worth $62.9K as of Q3 2026.
  • Harbor Asset Planning left its Novartis share count unchanged in Q3 2026.
  • Novartis made up 0.05% of Harbor Asset Planning's portfolio in Q3 2026, its #198 holding.
  • Harbor Asset Planning first reported a position in Novartis in Q2 2025 and has held it in 6 quarters since.
  • Harbor Asset Planning's Novartis position peaked at $69.1K in Q2 2026.
  • 1,256 funds tracked by Wall St. Rank held Novartis as of Q3 2026.

Based on Harbor Asset Planning's 13F filing for Q3 2026, filed 23 Oct 2026.